The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Biohaven Pharmaceuticals(NYSE:BHVN) 
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive t...
Website: http://www.biohavenpharma.com
Founded: 2013
Full Time Employees: 647
CEO: Vlad Coric
Sector: Healthcare
Industry: Biotechnology
Biohaven Pharmaceuticals Days Payable Outstanding ttm (DPO)
Biohaven Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Biohaven Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Biohaven Pharmaceuticals Op Cashflow Per Share ttm
Biohaven Pharmaceuticals Free Cashflow Per Share ttm
Biohaven Pharmaceuticals Cash Per Share ttm
Biohaven Pharmaceuticals P/S ratio ttm
Biohaven Pharmaceuticals (GAAP) P/E ratio ttm
Biohaven Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.